![](https://blogger.googleusercontent.com/img/b/R29vZ2xl/AVvXsEg1hM59Jd3KnMkrZCG_HtYYzFjarM-llB1L79TyBp4NeltAC5TnI25_42IkRUzm2Lcx32AGwYZ2hY_NAtOUT7d5WMZD5l3XkMQQNgLPHXht7_wykLINJKBlEcZktXz8Alk9XeubUrvcxkpr/s400-rw/Simultaneous+Estimation+of+Amlodipine+Besylate+%2526+Olmesartan+Medoximil.png)
Above shown are critical steps for HPLC method development. For spectrophotometric methods, linearity range was taken 2.5-12.5 μg/ml for Amlodipine Besylate and 5-25 μg/ml for Olmesartan Medoximil. Assay results of the marketed formulation were shown that % label claim of Amlodipine Besylate was in the range of 98.3-101.3% and % label claim of Olmesartan Medoximil was in the range of 98.3-101.1%. % recoveries of Amlodipine Besylate and Olmesartan Medoximil were obtained in the range of 98.13-102% and 98.86-101.60% respectively.
Hypertension is Regarded as the Silent Killer. It is a Disease of the modern age. Hypertension, most commonly refers to as “high blood pressure”, is a medical condition in which the blood pressure is chronically elevated. It was previously referred to as arterial hypertension, but in current usage, the word “hypertension” without a qualifier normally refers to arterial hypertension.
Author:-Chauhan Kalpana Nirmalsingh
Download
Advertisements:-
No comments:
Post a Comment